Cardiac troponin: Friend of the cardiac physician, foe to the cardiac patient?

Circulation

Volumn 114, Issue 16, 2006, Pages 1673-1675

  Wu, Alan H B ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Autoantibodies; Editorials; Heart failure; Myocardial infarction; Troponin

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CREATINE KINASE BB; CREATINE KINASE MB; CYTOKINE; MYOGLOBIN; TROPONIN; TROPONIN C; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; CARBOXY TERMINAL SEQUENCE; CARDIAC PATIENT; EDITORIAL; HEART FAILURE; HUMAN; MOUSE STRAIN; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARDIOLOGY; CARDIOVASCULAR DISEASES; HUMANS; MYOCARDIUM; PHYSICIANS; TROPONIN;

EID: 33750202413     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.652123     Document Type: Editorial

References (18)

1. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959-969.
2. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE 3rd, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC Jr, for the American College of Cardiology, American Heart Association, Committee on the Management of Patients With Unstable Angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2002;40:1366-1374.
3. Management of unstable angina: guidelines: 2000: the National Heart Foundation of Australia, the Cardiac Society of Australia and New Zealand. Med J Austral. 2000;173(suppl):S65-S88.
4. Fox KA, Birkhead J, Wilcox R, Knight C, Barth J, for the British Cardiac Society Working Group. British Cardiac Society Working Group on the definition of myocardial infarction. Heart. 2004;90:603-609.
5. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, Katus H. It's time for a change to a troponin standard. Circulation. 2000;102:1216-1220.
6. Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation. 2000;102:1221-1226.
7. Murphy AM, Kogler H, Georgakopoulos D, McDonough JL, Kass DA, Van Eyk JE, Marban E. Transgenic mouse model of stunned myocardium. Science. 2000;287:488-491.
8. Eriksson S, Hellman J, Pettersson K. Autoantibodies against cardiac troponins. N Engl J Med. 2005;352:98-100.
9. Berk JE, Kizu H, Wilding P, Searcy RL. Macroamylasemia: a newly recognized cause for elevated serum amylase activity. N Engl J Med. 1967;277:941-946.
10. Lee KN, Csako G, Bernhardt P, Elin RJ. Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. Clin Chem. 1994;40:1278-1283.
11. Fujita K. Takeya C. Saito T. Sakurabayashi I. Macro lactate dehydrogenase: an LDH-immunoglobulin M complex that inhibits lactate dehydrogenase activity in a patient's serum. Clin Chim Acta. 1984;140:183-195.
12. Litin SC, O'Brien JF, Pruett S, Forsman RW, Burritt MF, Bartholomew LG, Baldus WP. Macroenzyme as a cause of unexplained elevation of aspartate aminotransferase. Mayo Clinic Proc. 1987;62:681-687.
13. Eriksson S, Halenius H, Pulkki K, Hellman J, Pettersson K. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem. 2005;51:839-847.
14. Eriksson S, Ilva T, Becker C, Lund J, Porela P, Pulkki K, Voipio-Pulkki LM, Pettersson K. Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies. Clin Chem. 2005;51:803-804.
15. Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N, Honjo T. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med. 2003;9:1477-1483.
16. Göser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Öttl R, Zittrich S, Blaudeck N, Hardt SE, Pfitzer G, Rose NR, Katus HA, Kaya Z. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation. 2006;114:1693-1702.
17. Wu AHB, Fukushima F, Puskas R, Todd J, Goix P. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. Clin Chem. In press.
18. Chapelle JP, Dubois B, Bovy C, Aldenhoff MC, Gielen J, Rorive G. Comparison of plasma cardiac troponins T and I in chronically hemodialyzed patients in relation to cardiac status and age. Clin Chem Lab Med. 2002;40:240-245.